Gamma Light and Sound Stimulation to Prevent Dementia in Cognitively Normal People At Risk for Alzheimer's Disease
RecruitingNCT05776641Phase: NAStarted 2024-01-10
Summary
Alzheimer's disease (AD) is characterized by significant memory loss, toxic protein deposits (amyloid and tau) in the brain, and changes in the gamma frequency band on EEG. Gamma waves are important f
Eligibility
Sex
ALL
Min Age
55 Years
Max Age
90 Years
Locations
Massachusetts General HospitalBoston, Massachusetts, United States
Massachusetts Institute of TechnologyCambridge, Massachusetts, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05776641